top of page
  • NEWS Desk Global

AMYLYX'S ALS DRUGS


Amylyx Pharmaceuticals Inc's (AMLX.O)drug for amyotrophic lateral sclerosis (ALS) on Wednesday secured the support of external advisers to the U.S. Food and Drug Administration, months after the panel rejected it over issues with trial data.


0 views0 comments
bottom of page